摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Imidazo<1,2-b>-as-triazin | 275-00-3

中文名称
——
中文别名
——
英文名称
Imidazo<1,2-b>-as-triazin
英文别名
Imidazo[1,2-B][1,2,4]triazine
Imidazo<1,2-b>-as-triazin化学式
CAS
275-00-3
化学式
C5H4N4
mdl
MFCD18450046
分子量
120.114
InChiKey
SYLTXFOKMOCILU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    43.1
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

反应信息

  • 作为反应物:
    描述:
    Imidazo<1,2-b>-as-triazinsodium acetate碳酸氢钠乙酸乙酯Sodium sulfate-III 、 silica gel 、 Isohexane ethyl acetate 作用下, 以 溶剂黄146 为溶剂, 反应 0.55h, 以to afford 0.3147 g (74%) of the title compound的产率得到7-Bromoimidazo[1,2-b][1,2,4]triazine
    参考文献:
    名称:
    Imidazo-triazine derivatives as ligands for GABA receptors
    摘要:
    一类7-苯基咪唑[1,2-b][1,2,4]三嗪衍生物,其苯环的间位取代为直接连接或通过氧原子或—NH—键桥接的可选取代芳基或杂环芳基基团,是GABAA受体的选择性配体,特别是具有良好的α2和/或α3和/或α5亚单位的亲和力,因此对于治疗和/或预防中枢神经系统的不良症状,包括焦虑、惊厥和认知障碍具有益处。
    公开号:
    US06936608B2
  • 作为产物:
    描述:
    5,6-diphenyl-3,4,7,9-tetrazapentacyclo[9.7.1.02,10.04,8.015,19]nonadeca-1(18),2,5,7,9,11,13,15(19),16-nonaene 、 三氟乙酸 以0%的产率得到
    参考文献:
    名称:
    Druzhinin S. I., Dmitruk S. L., Kowalenko M. F., Uzhinow B. M., Zh. obshh. khimii, 63 (1993) N 6, S 1365- 1373
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Imidazo-triazine derivatives as ligands for gaba receptors
    申请人:——
    公开号:US20040023964A1
    公开(公告)日:2004-02-05
    A class of 7-phenylimidazo[1,2-b][1,2,4]triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, being selective ligands for GABA A receptors, in particular having good affinity for the &agr;2 and/or &agr;3 and/or &agr;5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
    一类7-苯基咪唑[1,2-b][1,2,4]三嗪衍生物,其苯环的间位被一个可选择取代的芳基或杂环芳基基团取代,该基团直接连接或由氧原子或-NH-键桥接,是选择性的GABAA受体配体,特别是具有良好的对α2和/或α3和/或α5亚单位的亲和力,因此对于治疗和/或预防中枢神经系统的不良症状,包括焦虑,惊厥和认知障碍具有益处。
  • KEEN B. T.; KRASS D. K.; PAUDLER W. W., J. HETEROCYCL. CHEM. <JHTC-AD>, 1976, 13, NO 4, 807-811
    作者:KEEN B. T.、 KRASS D. K.、 PAUDLER W. W.
    DOI:——
    日期:——
  • Druzhinin S. I., Dmitruk S. L., Kowalenko M. F., Uzhinow B. M., Zh. obshh. khimii, 63 (1993) N 6, S 1365- 1373
    作者:Druzhinin S. I., Dmitruk S. L., Kowalenko M. F., Uzhinow B. M.
    DOI:——
    日期:——
  • Imidazo-triazine derivatives as ligands for GABA receptors
    申请人:Bettati Michela
    公开号:US06936608B2
    公开(公告)日:2005-08-30
    A class of 7-phenylimidazo[1,2-b][1,2,4]triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, being selective ligands for GABA A receptors, in particular having good affinity for the α2 and/or α3 and/or α5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
    一类7-苯基咪唑[1,2-b][1,2,4]三嗪衍生物,其苯环的间位取代为直接连接或通过氧原子或—NH—键桥接的可选取代芳基或杂环芳基基团,是GABAA受体的选择性配体,特别是具有良好的α2和/或α3和/或α5亚单位的亲和力,因此对于治疗和/或预防中枢神经系统的不良症状,包括焦虑、惊厥和认知障碍具有益处。
查看更多

同类化合物

咪唑并[1,2-b][1,2,4]三唑并[4,3-D][1,2,4]三嗪 3-甲基咪唑并[1,2-b][1,2,4]噻嗪 3-溴-7-甲基咪唑并[1,2-b][1,2,4]三嗪 3-(三氟甲基)咪唑并[1,2-b][1,2,4]三嗪 2-咪唑并[1,2-B][1,2,4]三嗪-7-丙烷-2-醇 2-(3-溴咪唑并[1,2-b][1,2,4]-7-三嗪)丙烷-2-醇 3-(3-methylpyridin-2-yl)imidazo[1,2-b][1,2,4]triazine 2-imidazo[1,2-b][1,2,4]triazin-3-ylpropan-2-ol hydrochloride 2,2'-(7,7'-biimidazo[1,2-b][1,2,4]triazine-3,3'-diyl)dipropan-2-ol 2-(2,4-difluorophenyl)-6-((pyridin-2-yloxy)methyl)imidazo[1,2-b][1,2,4]triazine 2-(4-fluorophenyl)-7-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,2-b]-[1,2,4]-triazine 7-Bromo-2-methylimidazo[1,2-b][1,2,4]triazine 1,2,3,4-tetrahydro-dibenzo[4,5:e]imidazo[1,2-b][1,2,4]triazine 2-(7-bromo-imidazo[1,2-b][1,2,4]triazin-3-yl)-propan-2-ol imidazo[1,2-b][1,2,4]triazine-6-carboxylic acid ethyl ester 2-(imidazo[1,2-b][1,2,4]triazin-6-yl)ethanol 2-(4-fluorophenyl)-7-(4-methoxybenzyl)imidazo[1,2-b][1,2,4]triazine 7,9-Dimethylimidazo[1,2-b][1,2,4]benzotriazine 7-Methylimidazo[1,2-b][1,2,4]benzotriazine 7-Methoxyimidazo[1,2-b][1,2,4]benzotriazine imidazo[1,2-b][1,2,4]triazine-6-carbaldehyde 3-[3-trifluoromethylpyridin-2-yl]imidazo[1,2-b][1,2,4]triazin-7-amine 7-nitro-3-(3-trifluoromethylpyridin-2-yl)imidazo[1,2-b][1,2,4]triazine Imidazo[1,2-b][1,2,4]triazin-2(1H)-one 6-(3-Methoxycyclohexyl)-2-phenylimidazo[1,2-b][1,2,4]triazine 3-(3-trifluoromethylpyridin-2-yl)imidazo[1,2-b][1,2,4]triazine 2,3-diphenyl-6-thiophen-2-yl-imidazo[1,2-b][1,2,4]triazine 7-(2-chloropyridin-4-yl)-3-trifluoromethylimidazo[1,2-b][1,2,4]triazine 3-(1-fluoro-1-methylethyl)imidazo[1,2-b][1,2,4]triazine 7-[(3,4-dihydroxyphenyl)methylidene]-3-methyl-2-methylidene-1H-imidazo[1,2-b][1,2,4]triazin-6-one 6-(5-Chlorothiophen-2-yl)-2,3-dimethylimidazo[1,2-b][1,2,4]triazine 6-(5-Bromothiophen-2-yl)-2,3-dipyridin-2-ylimidazo[1,2-b][1,2,4]triazine 7-[(3,4-dihydroxyphenyl)methylidene]-3-ethyl-2-ethylidene-1H-imidazo[1,2-b][1,2,4]triazin-6-one 2-(5-{7-[2-(difluoromethoxy)benzyl]-6-methylimidazo[1,2-b][1,2,4]triazin-2-yl}-pyrimidin-2-yl)propan-2-ol 2-[2-Chloro-4-[2-[2-cyclopentyl-5-(imidazo[1,2-b][1,2,4]triazin-6-ylmethyl)-4,6-dioxooxan-2-yl]ethyl]phenyl]-2-methylpropanenitrile (7E)-3-methyl-2-methylidene-7-[(2,3,4-trimethoxyphenyl)methylidene]-1H-imidazo[1,2-b][1,2,4]triazin-6-one (3E)-3-[(2-chloro-6-fluorophenyl)methylidene]-1,6,7,8-tetrahydroimidazo[1,2-b][1,2,4]benzotriazin-2-one (3Z)-3-[(3-methoxyphenyl)methylidene]-1,6,7,8-tetrahydroimidazo[1,2-b][1,2,4]benzotriazin-2-one (12Z)-12-[(2,4-dichlorophenyl)methylidene]-1,2,8,10-tetrazatricyclo[7.3.0.03,7]dodeca-2,6,8-trien-11-one (12E)-12-[(4-chlorophenyl)methylidene]-1,2,8,10-tetrazatricyclo[7.3.0.03,7]dodeca-2,6,8-trien-11-one (3E)-3-(thiophen-2-ylmethylidene)-1,6,7,8-tetrahydroimidazo[1,2-b][1,2,4]benzotriazin-2-one (12E)-12-[[4-(dimethylamino)phenyl]methylidene]-1,2,8,10-tetrazatricyclo[7.3.0.03,7]dodeca-2,6,8-trien-11-one (7E)-7-[(2-methoxyphenyl)methylidene]-3-methyl-2-methylidene-1H-imidazo[1,2-b][1,2,4]triazin-6-one (3E)-3-[(3,4-dihydroxyphenyl)methylidene]-1,6,7,8-tetrahydroimidazo[1,2-b][1,2,4]benzotriazin-2-one (12E)-12-[(3,4,5-trimethoxyphenyl)methylidene]-1,2,8,10-tetrazatricyclo[7.3.0.03,7]dodeca-2,6,8-trien-11-one (12E)-12-[(2-methoxyphenyl)methylidene]-1,2,8,10-tetrazatricyclo[7.3.0.03,7]dodeca-2,6,8-trien-11-one 2-(Azepan-1-yl)-3-(1,1,2,2,2-pentafluoroethyl)imidazo[1,2-b][1,2,4]triazine 4-[(11-Hydroxy-1,2,8,10-tetrazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraen-12-yl)methylidene]-2-methoxycyclohexa-2,5-dien-1-one 2-(1-Adamantyl)-6,7,8,9-tetrahydroimidazo[1,2-b][1,2,4]benzotriazine 6-[1-(Furan-2-ylmethyl)-2,5-dimethylpyrrol-3-yl]-2,3-diphenylimidazo[1,2-b][1,2,4]triazine